Search

Mabruka Salem (University of Helsinki) and colleagues published a new paper on the isolation and characterization of three broad host range Yersinia phages. Phages were characterized with TEM, growth curves, burst size assays, and genome si

[Date change!] The sixth iVoM event will be Thursday, Mar 4, 11AM GMT (note earlier time than usual too!), and the theme will be "Biotechnology applications in health care". It will feature talks by: Laurent Debarbieux: Phages (in)action i

The 3rd Bacteriophage Therapy Summit is taking place virtually on March 23-25. With expert speakers from the FDA, BiomX, Cytophage, Loughborough University and Eligo Bioscience, join us online to progress fundamental bacteriophage research

Next week is Phage Futures 2021 (Feb 24-26)! Jessica and Jan of Phage Directory will be there, along with two dedicated social media assistants, Curtis Hoffmann and Atif Khan, to help keep you all in the loop via Twitter! (Another of our vo

Registration is open for (online) VEGA, Viral EcoGenomics & Applications, 2021. Hosted by the JGI, the goal of this series of online seminars is to bring together a “Viral Ecogenomics” community to foster discussion on how to best capture a

Phage/Virus Assembly 2021 will take place online July 27-30. Register here!

[Date change!] The sixth iVoM event will be Thursday, Mar 4, 11AM GMT (note earlier time than usual too!), and the theme will be "Biotechnology applications in health care". It will feature talks by: Laurent Debarbieux: Phages (in)action i

Prof. Mansel Griffiths (University of Guelph) and Dr. Hany Anany (Agriculture and Agri-Food Canada, Guelph Research and Development Center) are editing a special issue of Viruses entitled "Bacteriophages in Food Applications".

Call for papers for our special issue topic in Microorganisms, "Bacteriophages-Based Technologies for a One Health Society: Applications in Clinical, Veterinary, and Industrial Settings". Guest editors: Dr. Karen D. Weynberg, Dr. Sabrina Gr

A year ago on Twitter, Jeremy Barr (Monash University) shared a picture of several 40-year old phage stocks, and asked "what should we do with them?" People said 'check titre!' 'get WGS' and 'are they the same as the stock phages we've all

Phages are generally described as species-specific or even strain-specific, but how often do we really check? Daniel Cazares (Universidad Nacional Autónoma de México, Mexico) and colleagues pitted phages against a diverse collection of 600

Ali Khalid (Westmead Institute of Medical Research) and colleagues published a new paper in Frontiers in Microbiology entitled A Phage Therapy Guide for Clinicians and Basic Scientists: Background and Highlighting Applications for Developin

Elhanan Tzipilevich (Hebrew University-Hadassah Medical School) and colleagues published a new preprint showing that bacteria elicit a transient phage tolerance response subsequent to infection of their neighbors!

Quentin Lamy-Besnier (Institut Pasteur) and colleagues have created a Viral Host Range database, a tool that they built to gather, analyze and search experimental host-range information. They hope this will help leverage the experimental ho

Analysis of phage genomes replete with hypothetical genes is a challenge. Given the importance of genomic characterization of phages to understand their biology and for their safe use, International Bacteriophage Research Consortium (IBRC)

Phage enthusiasts need to take a 3-min break and watch this awesome student-made video breaking down phage lysogeny and the 'Piggyback the winner' hypothesis, set to the tune of a Justin Timberlake song... (no sound until around 0:26; then

Listen to soil phage ecologist Gary Trubl talk soil microbes and viral ecology on the Storytellers of STEMM podcast!

Viruses has an upcoming Special Issue on 'State-of-the-Art Phage Therapy Development in Europe'. They are looking for research articles, review articles and short communications related to: experimental and applied phage therapy; host–patho

FDA has cleared Adaptive Phage Therapeutics to start formally investigating use of its PhageBank™ to treat prosthetic joint infections. This gives APT the green light to start a phase 1/2 clinical trial in the first half of 2021 in collabor

Sabrina Green (Baylor College of Medicine) and colleagues published a new paper in MBio showing that a novel phage uses its tail fiber to bind to certain mammalian gut glycans, which helps it better target its host in the gut by localizing